Viewing Study NCT07454018

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2026-03-26 @ 3:20 PM
Ignite Modification Date: 2026-07-21 @ 11:43 PM
Study NCT ID: NCT07454018
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-03-06
First Post: 2026-02-09
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Iparomlimab/Tuvonralimab + Standard Chemotherapy and Olaparib in Platinum-Sensitive Recurrent Ovarian Cancer
Sponsor: The First Affiliated Hospital of Soochow University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Ovarian Cancer View
None Platinum-sensitive Ovarian Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Iparomlimab View
None Tuvonralimab View
None Epithelial ovarian cancer View
None Maintenance therapy View